EUDA HEALTH HOLDINGS LTD (EUDA) Fundamental Analysis & Valuation

NASDAQ:EUDA • VGG3142E1051

0.5107 USD
+0.02 (+4.22%)
At close: Mar 10, 2026
0.5195 USD
+0.01 (+1.72%)
Pre-Market: 3/11/2026, 8:00:57 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This EUDA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

1

Overall EUDA gets a fundamental rating of 1 out of 10. We evaluated EUDA against 101 industry peers in the Health Care Providers & Services industry. EUDA may be in some trouble as it scores bad on both profitability and health. EUDA has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

0

1. EUDA Profitability Analysis

1.1 Basic Checks

  • In the past year EUDA has reported negative net income.
  • EUDA had a negative operating cash flow in the past year.
  • EUDA had negative earnings in 4 of the past 5 years.
  • EUDA had a negative operating cash flow in each of the past 5 years.
EUDA Yearly Net Income VS EBIT VS OCF VS FCFEUDA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -5M -10M -15M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -723.54%, EUDA is doing worse than 97.03% of the companies in the same industry.
Industry RankSector Rank
ROA -723.54%
ROE N/A
ROIC N/A
ROA(3y)-557.55%
ROA(5y)-334.4%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EUDA Yearly ROA, ROE, ROICEUDA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 500 -500

1.3 Margins

  • Looking at the Gross Margin, with a value of 19.00%, EUDA is doing worse than 60.40% of the companies in the same industry.
  • EUDA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 19%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EUDA Yearly Profit, Operating, Gross MarginsEUDA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -100 -200 -300

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. EUDA Health Analysis

2.1 Basic Checks

  • EUDA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, EUDA has more shares outstanding
  • Compared to 1 year ago, EUDA has an improved debt to assets ratio.
EUDA Yearly Shares OutstandingEUDA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 10M 20M 30M
EUDA Yearly Total Debt VS Total AssetsEUDA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

  • EUDA has an Altman-Z score of -36.46. This is a bad value and indicates that EUDA is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -36.46, EUDA is doing worse than 90.10% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -36.46
ROIC/WACCN/A
WACC8.28%
EUDA Yearly LT Debt VS Equity VS FCFEUDA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

2.3 Liquidity

  • A Current Ratio of 0.23 indicates that EUDA may have some problems paying its short term obligations.
  • EUDA has a Current ratio of 0.23. This is amonst the worse of the industry: EUDA underperforms 92.08% of its industry peers.
  • EUDA has a Quick Ratio of 0.23. This is a bad value and indicates that EUDA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • EUDA's Quick ratio of 0.21 is on the low side compared to the rest of the industry. EUDA is outperformed by 91.09% of its industry peers.
Industry RankSector Rank
Current Ratio 0.23
Quick Ratio 0.21
EUDA Yearly Current Assets VS Current LiabilitesEUDA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. EUDA Growth Analysis

3.1 Past

  • The earnings per share for EUDA have decreased by -9.30% in the last year.
  • EUDA shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.22%.
EPS 1Y (TTM)-9.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%94.51%
Revenue 1Y (TTM)8.22%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%60.23%

3.2 Future

  • EUDA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 58.59% yearly.
  • EUDA is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 166.64% yearly.
EPS Next Y106.06%
EPS Next 2Y58.59%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year54.08%
Revenue Next 2Y166.64%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

EUDA Yearly Revenue VS EstimatesEUDA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2023 2024 2025 2026 10M 20M 30M 40M
EUDA Yearly EPS VS EstimatesEUDA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 0 0.1 -0.1 -0.2 -0.3

More info and screens

Find the best growth stocksShow best growing peers

4

4. EUDA Valuation Analysis

4.1 Price/Earnings Ratio

  • EUDA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • EUDA is valuated cheaply with a Price/Forward Earnings ratio of 2.95.
  • Based on the Price/Forward Earnings ratio, EUDA is valued cheaper than 100.00% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of EUDA to the average of the S&P500 Index (24.39), we can say EUDA is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 2.95
EUDA Price Earnings VS Forward Price EarningsEUDA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EUDA Per share dataEUDA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4

4.3 Compensation for Growth

  • EUDA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as EUDA's earnings are expected to grow with 58.59% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y58.59%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. EUDA Dividend Analysis

5.1 Amount

  • EUDA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

EUDA Fundamentals: All Metrics, Ratios and Statistics

EUDA HEALTH HOLDINGS LTD

NASDAQ:EUDA (3/10/2026, 8:21:10 PM)

Premarket: 0.5195 +0.01 (+1.72%)

0.5107

+0.02 (+4.22%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)06-14
Earnings (Next)N/A
Inst Owners0.12%
Inst Owner Change-87.78%
Ins Owners18.16%
Ins Owner Change0%
Market Cap19.31M
Revenue(TTM)4.01M
Net Income(TTM)-15.36M
Analysts82.86
Price Target6.12 (1098.36%)
Short Float %0.77%
Short Ratio0.24
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 2.95
P/S 4.81
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.47
EYN/A
EPS(NY)0.17
Fwd EY33.95%
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS0.11
BVpS-0.1
TBVpS-0.1
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -723.54%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 19%
FCFM N/A
ROA(3y)-557.55%
ROA(5y)-334.4%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover1.89
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 92.06%
Cap/Sales 2.98%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.23
Quick Ratio 0.21
Altman-Z -36.46
F-Score4
WACC8.28%
ROIC/WACCN/A
Cap/Depr(3y)85.16%
Cap/Depr(5y)58.08%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-9.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%94.51%
EPS Next Y106.06%
EPS Next 2Y58.59%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)8.22%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%60.23%
Revenue Next Year54.08%
Revenue Next 2Y166.64%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y34.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y22.18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y26.06%
OCF growth 3YN/A
OCF growth 5YN/A

EUDA HEALTH HOLDINGS LTD / EUDA FAQ

What is the fundamental rating for EUDA stock?

ChartMill assigns a fundamental rating of 1 / 10 to EUDA.


What is the valuation status of EUDA HEALTH HOLDINGS LTD (EUDA) stock?

ChartMill assigns a valuation rating of 4 / 10 to EUDA HEALTH HOLDINGS LTD (EUDA). This can be considered as Fairly Valued.


Can you provide the profitability details for EUDA HEALTH HOLDINGS LTD?

EUDA HEALTH HOLDINGS LTD (EUDA) has a profitability rating of 0 / 10.


How financially healthy is EUDA HEALTH HOLDINGS LTD?

The financial health rating of EUDA HEALTH HOLDINGS LTD (EUDA) is 0 / 10.